Elbit Imaging Ltd. (EMITF)
USD 1.2
(0.0%)
USD 1.2
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -37.8 Million ILS | -35.87% |
| 2022 | -27.82 Million ILS | -59.73% |
| 2021 | -17.42 Million ILS | -838.07% |
| 2020 | -1.85 Million ILS | -100.65% |
| 2019 | 284.39 Million ILS | 14.82% |
| 2018 | 247.68 Million ILS | -55.65% |
| 2017 | 558.43 Million ILS | -70.48% |
| 2016 | 1.89 Billion ILS | -6.01% |
| 2015 | 2.01 Billion ILS | -12.85% |
| 2014 | 2.3 Billion ILS | -44.49% |
| 2013 | 4.16 Billion ILS | -11.06% |
| 2012 | 4.67 Billion ILS | -35.85% |
| 2011 | 7.29 Billion ILS | 5.21% |
| 2010 | 6.93 Billion ILS | 37.79% |
| 2009 | 5.02 Billion ILS | 27.91% |
| 2008 | 3.93 Billion ILS | 36.47% |
| 2007 | 2.88 Billion ILS | 273.02% |
| 2006 | -1.66 Billion ILS | -191.02% |
| 2005 | 1.82 Billion ILS | -30.04% |
| 2004 | 2.61 Billion ILS | -26.96% |
| 2003 | 3.58 Billion ILS | -2.48% |
| 2002 | 3.67 Billion ILS | 53.51% |
| 2001 | 2.39 Billion ILS | 80.87% |
| 2000 | 1.32 Billion ILS | 220.1% |
| 1999 | 413.07 Million ILS | 133.89% |
| 1998 | -1.21 Billion ILS | -439.89% |
| 1997 | 358.65 Million ILS | 96.28% |
| 1996 | 182.72 Million ILS | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -38.34 Million ILS | 0.0% |
| 2024 Q1 | -38.34 Million ILS | -1.42% |
| 2023 Q3 | -37.8 Million ILS | -33.28% |
| 2023 Q2 | -28.36 Million ILS | 0.0% |
| 2023 FY | -37.8 Million ILS | -35.87% |
| 2023 Q1 | -28.36 Million ILS | -1.94% |
| 2023 Q4 | -37.8 Million ILS | 0.0% |
| 2022 Q1 | -3.4 Million ILS | 80.44% |
| 2022 Q3 | -27.82 Million ILS | -716.7% |
| 2022 Q2 | -3.4 Million ILS | 0.0% |
| 2022 Q4 | -27.82 Million ILS | 0.0% |
| 2022 FY | -27.82 Million ILS | -59.73% |
| 2021 Q3 | -17.42 Million ILS | -140.54% |
| 2021 Q4 | -17.42 Million ILS | 0.0% |
| 2021 Q2 | -7.24 Million ILS | 0.0% |
| 2021 FY | -17.42 Million ILS | -838.07% |
| 2021 Q1 | -7.24 Million ILS | -289.98% |
| 2020 Q4 | -1.85 Million ILS | 0.0% |
| 2020 Q1 | 485.99 Thousand ILS | -99.83% |
| 2020 Q2 | 485.99 Thousand ILS | 0.0% |
| 2020 Q3 | -1.85 Million ILS | -482.1% |
| 2020 FY | -1.85 Million ILS | -100.65% |
| 2019 Q1 | 42.11 Million ILS | -83.0% |
| 2019 FY | 284.39 Million ILS | 14.82% |
| 2019 Q3 | 272.82 Million ILS | 0.0% |
| 2019 Q4 | 284.39 Million ILS | 4.24% |
| 2018 Q4 | 247.68 Million ILS | 145.09% |
| 2018 Q1 | 580.44 Million ILS | 3.94% |
| 2018 Q3 | 101.06 Million ILS | -82.59% |
| 2018 Q2 | 580.44 Million ILS | 0.0% |
| 2018 FY | 247.68 Million ILS | -55.65% |
| 2017 Q4 | 558.43 Million ILS | 0.0% |
| 2017 FY | 558.43 Million ILS | -70.48% |
| 2017 Q1 | 1.53 Billion ILS | -18.6% |
| 2017 Q2 | 1.53 Billion ILS | 0.0% |
| 2017 Q3 | 558.43 Million ILS | -63.74% |
| 2016 FY | 1.89 Billion ILS | -6.01% |
| 2016 Q4 | 1.89 Billion ILS | -4.36% |
| 2016 Q3 | 1.97 Billion ILS | -2.59% |
| 2016 Q2 | 2.03 Billion ILS | -2.72% |
| 2016 Q1 | 2.08 Billion ILS | 226.38% |
| 2015 Q1 | 2.21 Billion ILS | 236.13% |
| 2015 Q2 | 1.99 Billion ILS | -10.2% |
| 2015 Q3 | 2.03 Billion ILS | 2.21% |
| 2015 Q4 | 639.61 Million ILS | -68.61% |
| 2015 FY | 2.01 Billion ILS | -12.85% |
| 2014 Q2 | 2.5 Billion ILS | 1.76% |
| 2014 FY | 2.3 Billion ILS | -44.49% |
| 2014 Q4 | 660.45 Million ILS | -72.29% |
| 2014 Q3 | 2.38 Billion ILS | -4.67% |
| 2014 Q1 | 2.45 Billion ILS | -40.94% |
| 2013 FY | 4.16 Billion ILS | -11.06% |
| 2013 Q4 | 4.16 Billion ILS | -1.34% |
| 2013 Q3 | 4.21 Billion ILS | 3.4% |
| 2013 Q2 | 4.07 Billion ILS | -5.24% |
| 2013 Q1 | 4.3 Billion ILS | 0.0% |
| 2012 Q1 | 5.63 Billion ILS | 0.0% |
| 2012 Q4 | - ILS | -100.0% |
| 2012 Q2 | 4.33 Billion ILS | -22.94% |
| 2012 FY | 4.67 Billion ILS | -35.85% |
| 2012 Q3 | 4.71 Billion ILS | 8.71% |
| 2011 Q2 | 7.35 Billion ILS | -0.43% |
| 2011 Q1 | 7.38 Billion ILS | 0.0% |
| 2011 FY | 7.29 Billion ILS | 5.21% |
| 2011 Q4 | - ILS | -100.0% |
| 2011 Q3 | 7.18 Billion ILS | -2.33% |
| 2010 FY | 6.93 Billion ILS | 37.79% |
| 2010 Q2 | 7.31 Billion ILS | 44.87% |
| 2010 Q3 | 7.32 Billion ILS | 0.12% |
| 2010 Q1 | 5.04 Billion ILS | -1.84% |
| 2010 Q4 | - ILS | -100.0% |
| 2009 FY | 5.02 Billion ILS | 27.91% |
| 2009 Q3 | 4.88 Billion ILS | -1.22% |
| 2009 Q2 | 4.94 Billion ILS | 14.48% |
| 2009 Q1 | 4.32 Billion ILS | 9.92% |
| 2009 Q4 | 5.14 Billion ILS | 5.25% |
| 2008 FY | 3.93 Billion ILS | 36.47% |
| 2008 Q2 | 3.6 Billion ILS | 57.02% |
| 2008 Q1 | 2.29 Billion ILS | -20.31% |
| 2008 Q3 | 3.35 Billion ILS | -6.89% |
| 2008 Q4 | 3.93 Billion ILS | 17.14% |
| 2007 Q4 | 2.88 Billion ILS | 270.13% |
| 2007 Q3 | -1.69 Billion ILS | -52.28% |
| 2007 Q2 | -1.11 Billion ILS | -3.83% |
| 2007 Q1 | -1.07 Billion ILS | 35.68% |
| 2007 FY | 2.88 Billion ILS | 273.02% |
| 2006 Q3 | -310.9 Million ILS | 20.28% |
| 2006 Q4 | -1.66 Billion ILS | -435.58% |
| 2006 Q1 | -445.84 Million ILS | -124.37% |
| 2006 FY | -1.66 Billion ILS | -191.02% |
| 2006 Q2 | -389.99 Million ILS | 12.53% |
| 2005 Q2 | 483.46 Million ILS | -83.11% |
| 2005 Q3 | 41.3 Million ILS | -91.46% |
| 2005 FY | 1.82 Billion ILS | -30.04% |
| 2005 Q4 | 1.82 Billion ILS | 4328.78% |
| 2005 Q1 | 2.86 Billion ILS | 9.44% |
| 2004 Q2 | 3.66 Billion ILS | 0.0% |
| 2004 Q3 | 2.2 Billion ILS | -39.82% |
| 2004 FY | 2.61 Billion ILS | -26.96% |
| 2004 Q4 | 2.61 Billion ILS | 18.43% |
| 2003 Q3 | 3.39 Billion ILS | 2.84% |
| 2003 Q4 | 3.58 Billion ILS | 5.6% |
| 2003 Q1 | 3.72 Billion ILS | 1.47% |
| 2003 Q2 | 3.29 Billion ILS | -11.5% |
| 2003 FY | 3.58 Billion ILS | -2.48% |
| 2002 Q1 | - ILS | -100.0% |
| 2002 FY | 3.67 Billion ILS | 53.51% |
| 2002 Q2 | - ILS | 0.0% |
| 2002 Q4 | 3.67 Billion ILS | 3.76% |
| 2002 Q3 | 3.53 Billion ILS | 0.0% |
| 2001 Q1 | - ILS | -100.0% |
| 2001 Q4 | 2.39 Billion ILS | 0.0% |
| 2001 FY | 2.39 Billion ILS | 80.87% |
| 2001 Q3 | - ILS | 0.0% |
| 2000 FY | 1.32 Billion ILS | 220.1% |
| 2000 Q1 | - ILS | -100.0% |
| 2000 Q4 | 1.32 Billion ILS | 28.02% |
| 2000 Q3 | 1.03 Billion ILS | 0.0% |
| 2000 Q2 | - ILS | 0.0% |
| 1999 FY | 413.07 Million ILS | 133.89% |
| 1999 Q4 | 413.07 Million ILS | 0.0% |
| 1998 FY | -1.21 Billion ILS | -439.89% |
| 1998 Q4 | -1.21 Billion ILS | 0.0% |
| 1997 FY | 358.65 Million ILS | 96.28% |
| 1997 Q4 | 358.65 Million ILS | 0.0% |
| 1996 Q4 | 182.72 Million ILS | 0.0% |
| 1996 FY | 182.72 Million ILS | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | -44.12% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -539971.429% |
| Össur hf. | 395.08 Million USD | 109.569% |
| QHSLab, Inc. | 1.72 Million USD | 2285.298% |
| Wellstar International, Inc. | 51.36 Million USD | 173.598% |
| Össur hf. | 395.08 Million USD | 109.569% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 12075.507% |
| Aurora Spine Corporation | 1.9 Million USD | 2081.752% |
| BrainsWay Ltd. | -10.32 Million USD | -266.328% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 354.982% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 308.567% |
| Vivos Inc. | -1.59 Million USD | -2274.258% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 7857.529% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | -6888.166% |
| Zecotek Photonics Inc. | 2.76 Million USD | 1468.532% |
| Avitar, Inc. | 5.17 Million USD | 831.074% |
| Nanomix Corporation | 11.38 Million USD | 431.939% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | -718.791% |
| Theraclion SA | -5.86 Million EUR | -544.638% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | 1.68 Million USD | 2341.12% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 2446.909% |
| Lombard Medical, Inc. | 11.49 Million USD | 428.882% |
| ALR Technologies Inc. | 19.14 Million USD | 297.433% |
| Stratec SE | 119.12 Million USD | 131.736% |
| Vycor Medical, Inc. | 1.05 Million USD | 3690.365% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 68842.613% |
| MicroPort Scientific Corporation | 673.58 Million USD | 105.613% |
| VMS Rehab Systems, Inc. | 133.52 USD | 28314210.246% |
| NewCardio, Inc. | 2.41 Million USD | 1665.408% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 2677.03% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 6092.053% |
| Odyssey Group International, Inc. | 2.1 Million USD | 1893.58% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 6005.214% |
| Wellness Center USA, Inc. | 3.98 Million USD | 1048.568% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 225.402% |
| IR-Med Inc. | -606 Thousand USD | -6138.449% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | -174.202% |
| Polarean Imaging plc | -5.94 Million USD | -535.748% |
| United American Healthcare Corporation | -9.32 Million USD | -305.329% |
| ECGI Holdings, Inc. | 3.17 Million USD | 1292.119% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 40665.916% |
| Capital Group Holdings, Inc. | -3508.00 USD | -1077579.59% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 14495.434% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 17553.187% |
| Urologix, Inc. | 4.61 Million USD | 919.177% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 998.104% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 1234.86% |
| SS Innovations International, Inc. | 1.18 Million USD | 3289.367% |
| Qualis Innovations, Inc. | 6671.00 USD | 566806.641% |
| Smith & Nephew plc | 2.77 Billion USD | 101.361% |
| NIOX Group Plc | -23.93 Million USD | -57.966% |
| Fuse Medical, Inc. | 1.75 Million USD | 2253.524% |
| Broncus Holding Corporation | -81.42 Million USD | 53.571% |
| Brain Scientific Inc. | 2.11 Million USD | 1886.819% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 266.71% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 95670.948% |